Regeneron Pharmaceuticals Inc (NASDAQ:REGN) - Share price - Overview

Stock Report

Regeneron Pharmaceuticals Inc REGN

Last Price
$372.32

Day Change
0.00|0.00%

As of 25/04/2017
16:49:57 EST | USD
Minimum 15 Minutes Delay.

Last Close372.32
Day Range370.01 - 376.00
Mkt Cap39.50Bil
52-Wk Range325.62 - 452.83
Yield %-
ISINUS75886F1075
Volume267,280
P/E48.35
P/S8.91
P/CF29.41

Share Price

Financials
201420152016
More ...
Income Statement
Revenue2,819.564,103.734,860.43
Operating Income838.431,251.921,330.74
Net Income348.07636.06895.52
Basic EPS3.466.178.55
Avg. Diluted Shares Outstanding113115116
Balance Sheet
Current Assets2,167.462,915.103,180.19
Non Current Assets1,704.372,694.043,793.28
Total Assets3,871.835,609.136,973.47
Current Liabilities654.66811.161,241.50
Total Liabilities1,329.501,954.302,524.22
Total Equity2,542.333,654.844,449.25
Cash Flow
Operating Cash Flow743.161,330.781,473.40
Capital Expenditure-333.01-677.93-511.94
Free Cash Flow410.15652.85961.46

In millions, except "Basic EPS". Currency is USD.

Company Profile

Regeneron Pharmaceuticals Inc is a fully integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

5,400
Key Stats
More ...
Price/Earning TTM43.55
Price/Book8.88
Price/Sales TTM8.91
Rev Growth (3 year avg)32.18
EPS Growth (3 year avg)-
Operating Margin % TTM27.38
Net Margin % TTM18.42
ROE TTM22.10
Debt/Equity0.08
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.